strategies for the management of ebv-ptld
Published 2 years ago • 535 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
2:24
the treatment and management of ptld
-
2:26
advances in ebv-ptld
-
3:16
tabelecleucel in the treatment of ebv ptld
-
1:58
clinical outcomes of patients with ebv-ptld who fail rituximab following hsct
-
3:29
tabelecleucel for treating ebv associated ptld
-
0:58
management strategies for acute and chronic gvhd following allosct
-
6:47
hovid bhd (strategic management 2019) bpmn 6023 uum
-
10:37
ebv diagnostics
-
7:53
diseases associated with the epstein-barr virus
-
1:51
how to manage tumor flare after administration of bispecific antibodies
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
2:21
tab-cel for solid organ or allogeneic transplant recipients with ebv-ptld
-
4:42
ptcl arising as a ptld: the efficacy of pralatrexate
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis
-
1:41
transplant optimization strategies
-
1:31
hma combination strategies in mds: blc2, cd47 & tim-3 inhibitors
-
4:22
management of btk class driven adverse events
-
1:29
improving virus-specific t-cell therapy
-
3:10
is there a benefit to rituximab maintenance after first-line bendamustine-rituximab for mcl?
-
8:24
viral lymphomas: risk factors and treatments
-
2:13
exciting agents and treatment approaches emerging in the field of myelofibrosis
-
2:22
the challenges with monitoring patients with lymphoma for cardiotoxicity